George A. Jacoby focuses on Microbiology, Plasmid, Antibacterial agent, Klebsiella pneumoniae and Drug resistance. The various areas that he examines in his Microbiology study include Enterobacteriaceae, Gene and Escherichia coli. His Plasmid study incorporates themes from Quinolone, Enterobacter cloacae and DNA gyrase.
His biological study spans a wide range of topics, including Efflux and Multiple drug resistance. His studies in Klebsiella pneumoniae integrate themes in fields like Ceftazidime and Porin. George A. Jacoby focuses mostly in the field of Drug resistance, narrowing it down to matters related to Nalidixic acid and, in some cases, Pseudomonas aeruginosa.
His primary scientific interests are in Microbiology, Plasmid, Escherichia coli, Genetics and Gene. His work deals with themes such as Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacteriaceae, which intersect with Microbiology. His research integrates issues of Ceftazidime and Virology in his study of Klebsiella pneumoniae.
His Enterobacteriaceae study combines topics in areas such as Peptide sequence and Cephalosporin. The concepts of his Plasmid study are interwoven with issues in DNA gyrase, Enzyme, Efflux, Drug resistance and Pseudomonas. His Escherichia coli research includes themes of Ciprofloxacin, Mutant and Molecular biology.
His primary areas of investigation include Microbiology, Plasmid, Genetics, Gene and DNA gyrase. The study incorporates disciplines such as Efflux and Enterobacter cloacae, Enterobacteriaceae, Escherichia coli in addition to Microbiology. His work in the fields of Quinolone resistance overlaps with other areas such as DnaA.
His study in the field of Topoisomerase-II Inhibitor, Plasmid maintenance, Bacterial genetics and Citrobacter is also linked to topics like Antitoxin. He combines subjects such as Ciprofloxacin, Multiple drug resistance, DNA and Quinolone with his study of DNA gyrase. His Ciprofloxacin research is multidisciplinary, relying on both Klebsiella pneumoniae and Virology.
George A. Jacoby mainly investigates Plasmid, Microbiology, Genetics, Gene and Drug resistance. His study in Plasmid is interdisciplinary in nature, drawing from both Klebsiella pneumoniae and DNA gyrase. His Microbiology research incorporates elements of Enterobacter cloacae and Enterobacteriaceae.
His Enterobacteriaceae research includes elements of Pseudomonas aeruginosa, Aztreonam and Ceftazidime. His research investigates the link between Drug resistance and topics such as Antibacterial agent that cross with problems in Ciprofloxacin and Virology. His Efflux research is multidisciplinary, incorporating perspectives in Topoisomerase IV and Quinolone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A functional classification scheme for beta-lactamases and its correlation with molecular structure.
Karen Bush;George A. Jacoby;Andantone A. Medeiros.
Antimicrobial Agents and Chemotherapy (1995)
Updated Functional Classification of β-Lactamases
Karen Bush;George A. Jacoby.
Antimicrobial Agents and Chemotherapy (2010)
AmpC β-Lactamases
George A. Jacoby.
Clinical Microbiology Reviews (2009)
Quinolone resistance from a transferable plasmid
Luis Martínez-Martínez;Alvaro Pascual;George A Jacoby.
The Lancet (1998)
Plasmid-Determined AmpC-Type β-Lactamases
Alain Philippon;Guillaume Arlet;George A. Jacoby.
Antimicrobial Agents and Chemotherapy (2002)
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Ari Robicsek;Jacob Strahilevitz;George A Jacoby;Mark Macielag.
Nature Medicine (2006)
The worldwide emergence of plasmid-mediated quinolone resistance
Ari Robicsek;Ari Robicsek;George A Jacoby;George A Jacoby;David C Hooper.
Lancet Infectious Diseases (2006)
Tackling antibiotic resistance
Karen Bush;Patrice Courvalin;Gautam Dantas;Julian Davies.
Nature Reviews Microbiology (2011)
Mechanisms of resistance to quinolones
George A. Jacoby.
Clinical Infectious Diseases (2005)
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Jacob Strahilevitz;George A. Jacoby;David C. Hooper;Ari Robicsek.
Clinical Microbiology Reviews (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Massachusetts General Hospital
Indiana University
University of Seville
University of Córdoba
Beth Israel Deaconess Medical Center
IHMA
Brown University
University of Turku
University of Florence
Harvard University
University College London
Nvidia (United States)
Erasmus University Rotterdam
University of Oxford
National University of Defense Technology
Henan Normal University
Southeast University
Chinese Academy of Sciences
BC Cancer Agency
Agricultural Research Service
Council of Scientific and Industrial Research
Tufts University
University of Genoa
Heidelberg University
Istituto Giannina Gaslini
Morehouse School of Medicine